Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: Hong Kong Clear all

117 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20043
20054
20062
20074
20087
20099
201014
20112
20124
20134
20143
20154
20163
20175
20186
20197
20207
20216
20225
20232
20245
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed75
Terminated14
Recruiting10
Unknown status10
Active, not recruiting4
Not yet recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong20
Novo Nordisk A/S17
The University of Hong Kong15
AstraZeneca11
Boehringer Ingelheim8
Hoffmann-La Roche8
Takeda6
GlaxoSmithKline4
Sanofi4
Bayer3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2117
Diabetes Mellitus28
Obesity7
Diabetic Nephropathies5
Hypertension5
Overweight4
Renal Insufficiency, Chronic4
Acute Coronary Syndrome3
Cardiovascular Diseases3
Diabetes Mellitus, Type 13

Trials

Showing 1 to 25 of 117. Each trial links to its page on Pharma Observatory.

17 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.